tiprankstipranks
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market

Neuphoria Therapeutics (NEUP) Income Statement

Compare
238 Followers

Neuphoria Therapeutics Income Statement

Last quarter (Q1 2025), Neuphoria Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q1, Neuphoria Therapeutics's net income was AU$-804.79K. See Neuphoria Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 22Jun 21Jun 20
Total Revenue
AU$ 0.00AU$ 260.00KAU$ 0.00AU$ 50.00K
Gross Profit
AU$ -434.45KAU$ -6.87MAU$ -3.62MAU$ -1.96M
Operating Expenses
AU$ 17.89BAU$ 21.61MAU$ 11.92MAU$ 9.06M
Depreciation and Amortization
AU$ 434.45KAU$ 804.53KAU$ 1.27MAU$ 1.64M
EBITDA
AU$ -9.84MAU$ -11.51MAU$ -4.97MAU$ -4.19M
Operating Income
AU$ -17.89BAU$ -21.34MAU$ -11.92MAU$ -9.01M
Other Income/Expenses
AU$ 17.88BAU$ -3.01MAU$ 1.04MAU$ 4.85M
Pretax Income
AU$ -10.27MAU$ -21.95MAU$ -8.88MAU$ -6.03M
Net Income
AU$ -15.49BAU$ -21.76MAU$ -8.70MAU$ -7.12M
Per Share Metrics
Basic EPS
AU$ -1.02AU$ -0.02AU$ -0.01AU$ -0.01
Diluted EPS
AU$ -1.02AU$ -0.02AU$ -0.01AU$ -0.01
Weighted Average Shares Outstanding
9.99M 1.35B 779.88M 544.83M
Weighted Average Shares Outstanding (Diluted)
9.99M 1.35B 779.88M 544.83M
Currency in AUD

Neuphoria Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis